Men with high estrogen levels could be at greater risk of breast cancer
New research indicates that men with naturally high levels of the female hormone estrogen may have a greater risk of developing breast cancer.
New research indicates that men with naturally high levels of the female hormone estrogen may have a greater risk of developing breast cancer.
What vaginal lubricants are available for for women with hormone-receptor positive (HR+) cancer?
Aerobic exercise may reduce breast cancer risk by changing estrogen metabolism to produce more of the metabolites that keep the disease at bay.
Most older women with early breast cancer are more likely to avoid mastectomy by following lumpectomy with radiation, contrary to current thinking.
Coadministration of anastrozole (Arimidex) and fulvestrant (Faslodex) improved survival in women with HR-positive metastatic breast cancer.
Overweight women with breast cancer were found to have more estrogen remaining after hormone-suppressing therapy than did women of healthy weight.
Using positron emission tomography (PET) to image progesterone receptor status in breast tumors may show who on hormone therapy will benefit.
For women with estrogen receptor-positive breast cancer, mutations ID aromatase inhibitor response.
A vaccine significantly increased survival in mice with breast cancer when given with the hormonal therapy letrozole, but not with tamoxifen.
Risk increased with estrogen, estrogen progesterone; no increase in fatal breast cancer.